Project Grant ED20ATL3070060

Federal Cooperative Agreement Summary IMPACT-CETR: Immunization Against Multidrug-Resistant Pathogens Boston Children's Hospital has been awarded $9.55 million through a Cooperative Agreement funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award, effective August 19, 2025, with a completion date of June 30, 2030, establishes the Immunization Against Multidrug-Resistant Pathogens:...

The National Science Foundation awarded a $195,381 Project Grant to Washington State University under the Biological Sciences program (CFDA 47.074) for the period of February 1, 2021 through January 31, 2024. The grant aims to fund the RAPID project "Curtailing Nosocomial Amplification of COVID-19," which seeks to develop epidemiological models to better understand and mitigate the transmission of COVID-19 in healthcare settings. As part of the grant, Research Triangle Institute will...

This $1,000,000 Cooperative Agreement awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) supports research and development efforts by Akanocure Pharmaceuticals Inc. to optimize a novel, broad-spectrum antiviral and immunomodulatory agent for oral administration against coronaviruses. The project focuses on lead optimization, including the design, synthesis, and testing of analogs with improved drug-like properties for...

Federal Cooperative Agreement Summary The National Center for Advancing Translational Sciences (NCATS), under CFDA 93.350, awarded a Cooperative Agreement totaling $41.3 million to the University of California, San Diego for the Altman Clinical and Translational Research Institute (ACTRI). The award, effective August 1, 2025, with completion scheduled for April 30, 2032, supports the rapid translation of scientific discoveries into innovative health solutions through clinical and translational...

The Maine Community College System (MCCS) was awarded a $415,882 Supplemental Support under the American Rescue Plan (SSARP) project grant by the U.S. Department of Education's Office of Postsecondary Education. The grant falls under the Education Stabilization Fund program (CFDA 84.425), which aims to prevent, prepare for, and respond to the coronavirus pandemic. Through this July 2022 award, MCCS and its sub-awardee, Kennebec Valley Community College, will provide supplemental support services...

The National Institutes of Health Office of the Director awarded Arizona State University a $1,520,910 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to implement the "BACK TO ECE SAFELY WITH SAGE: REDUCING COVID-19 TRANSMISSION IN HISPANIC AND LOW-INCOME PRESCHOOLERS" project from June 30, 2021 through June 29, 2022. The grant aims to reduce COVID-19 transmission among Hispanic and low-income preschoolers through the delivery of services including COVID-19...

Coconino Community College was awarded a $309,641 Supplemental Support under the American Rescue Plan (SSARP) Project Grant from the U.S. Department of Education's Office of Postsecondary Education. The grant was awarded on July 14, 2022 under the Education Stabilization Fund program (CFDA 84.425) to prevent, prepare for, and respond to the coronavirus COVID-19 pandemic. The funding will support Coconino Community College in delivering products and services to address the impacts of the COVID-19...

Federal Cooperative Agreement Summary Research Triangle Institute (RTI International) received a Cooperative Agreement award of $805,722 from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective August 6, 2025, through July 31, 2030. The award supports the Continued Pressure for Alveolar Protection: A Randomized Controlled Trial (CPAP Trial), a clinical research initiative addressing...

Federal Grant Award Summary Autonomous Therapeutics Inc. received a $1,004,473 Phase II Small Business Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded September 10, 2025, with completion scheduled for August 31, 2028. The project focuses on translating AT191, a first-in-class encrypted RNA (EncRNA) therapeutic candidate designed to provide inhaled,...

The National Science Foundation awarded a $255,961 Small Business Technology Transfer Phase I Project Grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to Rush River Research Corp. The grant aims to develop a low-cost, automated receptacle for rapid point-of-care sterilization of personal protective equipment, such as filtering facepiece respirators, for frontline healthcare workers during the COVID-19 pandemic. Specifically, the company will construct and...